Europe’s largest and most established orphan drug & rare disease meeting will take place from 26 to 28 October 2026 in Amsterdam, The Netherlands.
Covering the full orphan drug value chain, the congress will bring together researchers, industry, policymakers and other stakehorlders around topics including cell and gene therapies, genetic testing, market access and real-worl evidence.
The event will begin with a Workshop Day on 26 October, followed by the Conference & Exhibition on 27-28 October.
From 26-28 October 2026, RAI Convention Center, Amsterdam, The Netherlands.